3 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Withdrawn 3 |
Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis AIN457 - Uveitis | Phase 3 | Withdrawn | Novartis Pharmaceuticals | 2011-03-01 | 2013-12-06 | |
| Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis AIN457, Placebo - Uveitis | Phase 3 | Withdrawn | Novartis | 2010-12-01 | 2020-09-29 | |
| Intravitreal Bevacizumab for Inflammatory Neovascular Membranes Bevacizumab, Intravitreal Injection of Bevacizumab - Vogt Koyanagi Harada Disease, Serpiginous Choroiditis | Phase 3 | Withdrawn | Asociación para Evitar la Ceguera en México | 2006-12-01 | 2024-05-30 |
Panuveitis (2) · Uveitis, Intermediate (2) · Uveitis, Posterior (2) · Multifocal Choroiditis (1) · Uveomeningoencephalitic Syndrome (1) · White Dot Syndromes (1)
Eye Diseases (3) · Uveal Diseases (3) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Choroid Diseases (1) · Choroiditis (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Panuveitis (1) · Uveitis, Posterior (1)
secukinumab (2) · Bevacizumab (1)
Asociación para Evitar la Ceguera en México (1) · Novartis (1) · Novartis Pharmaceuticals (1)
Canada (1) · Israel (1) · Japan (1) · Mexico (1) · Switzerland (1) · United States (1)
LuzElena Concha-Del Rio, MD (1) · Veronica Kon-Jara, MD (1)
2009 (1)